UK markets open in 7 hours 37 minutes

Zymeworks Inc. (ZYME)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.76+0.18 (+2.10%)
At close: 04:00PM EDT
8.85 +0.09 (+1.03%)
After hours: 06:42PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.58
Open8.56
Bid8.72 x 100
Ask8.78 x 100
Day's range8.55 - 9.00
52-week range6.01 - 13.14
Volume447,030
Avg. volume576,662
Market cap618.177M
Beta (5Y monthly)1.11
PE ratio (TTM)N/A
EPS (TTM)-1.72
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.96
  • GlobeNewswire

    Zymeworks Announces Participation in Upcoming Investor Conferences

    VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management will participate in one-on-one meetings on May 15th in Las

  • Simply Wall St.

    We Think Zymeworks (NASDAQ:ZYME) Can Afford To Drive Business Growth

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...

  • GlobeNewswire

    Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

    VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will report its first quarter 2024 financial results after market close on May 2, 2024. Following the announcement, management will host a conference call and webcast to discuss financial results a